Consumers in the U.K. say trust is an important factor when it comes to the companies where they shop. This is why Newsweek ...

Bausch + Lomb will manage IND-enabling studies, clinical development, regulatory submissions, and commercialization if they pursue the candidate. City Therapeutics retains technology rights, with ...

London, UK, 13 January 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing ...

Brent Saunders, Bausch and Lomb CEO, joins 'Money Movers' to discuss how Saunders has changed the portfolio in his time as chief executive, what the growth is like for Bausch and Lomb, and much more.

In this article, we are going to take a look at where Bausch Health Companies Inc ... which he believes are not the solution to the obesity problem. Additionally, Kennedy has advocated for ...

As the brain’s reward system shifts to prioritize meaning and purpose over raw achievement, projects that focus on legacy-building often feel most fulfilling. Writing a book, delivering keynote ...